India ranks as the world's second largest nutraceuticals market by value. Roughly 25,000 ayurvedic and herbal manufacturing units supply ingredients and finished products. Employment figures, logistics costs, and supplement adoption rates add further detail to the current picture.
Key Takeaways
- FICCI study estimates India has ~25,000 ayurvedic/herbal product manufacturing/processing units that can supply nutraceutical ingredients and products (study framing)
- India’s formal manufacturing employment rose from 27.7 million in FY2017 to 33.2 million in FY2022 per the Annual Survey of Industries—employment series published by India’s Ministry of Statistics & Programme Implementation
- India’s MSMEs in the manufacturing sector totaled 8.05 million in 2022 per Government of India MSME Annual Report
- 9.5% CAGR for India’s nutraceuticals market forecast for 2024–2032 per IMARC Group
- India is the world’s second-largest market for nutraceuticals by value (global rank in the nutraceuticals market outlook) per GlobalData’s market outlook coverage referenced in trade reporting
- USD 1.6 billion in 2020 is the value of medicinal plant exports from India (exports of medicinal plants, aligned to trade records).
- Vitamin and mineral supplements accounted for the largest share in India’s dietary supplement sales in 2021 (industry panel share statistic) per Euromonitor research excerpt published by an approved media partner
- India is among the top global exporters of medicinal plants: exports of medicinal plants from India were valued at USD 1.6 billion in 2020 (ITC/UN Comtrade-aligned reporting cited by TRAFFIC/WWF trade publication)
- India’s retail sales of packaged foods grew at a double-digit rate in 2023 (context for nutraceutical packaging and distribution), with packaged food sales growth reported at 12% YoY in 2023 by a public industry dataset
- India’s food inflation averaged about 6% in 2023 (context for nutraceutical ingredient and logistics costs) per RBI’s inflation report data table
- India’s wholesale price inflation (WPI) for food articles was around 7% in 2022 (cost pressure on ingredients and processing) per RBI WPI series bulletin data
- In a 2022 consumer survey published in an Indian public health journal, 48% of surveyed Indian adults reported using health supplements to manage energy/health goals (survey-based adoption statistic)
- A 2021 systematic review on dietary supplement use in India reported pooled prevalence of supplement use around 30% across included studies (meta-analytic adoption statistic)
- In a 2020 cross-sectional study in an Indian urban population, 63% of participants reported willingness to purchase immunity-related supplements during outbreaks (adoption intent statistic)
- ₹3,500+ crore is the annual market size for probiotics in India in 2023 (major nutraceutical segment used for gut-health supplementation).
India’s nutraceutical market is set to surge, supported by rapid demand growth, strong manufacturing capacity, and rising online adoption.
Related reading
01 · Category
Employment & Workforce3 stats
01
FICCI study estimates India has ~25,000 ayurvedic/herbal product manufacturing/processing units that can supply nutraceutical ingredients and products (study framing)
02
India’s formal manufacturing employment rose from 27.7 million in FY2017 to 33.2 million in FY2022 per the Annual Survey of Industries—employment series published by India’s Ministry of Statistics & Programme Implementation
03
India’s MSMEs in the manufacturing sector totaled 8.05 million in 2022 per Government of India MSME Annual Report
Interpretation
Employment & Workforce Interpretation
The Employment & Workforce data suggests the nutraceutical ingredient supply chain is supported by a large and expanding industrial workforce, with formal manufacturing employment increasing from 27.7 million in FY2017 to 33.2 million in FY2022 and with India also hosting about 25,000 ayurvedic and herbal product manufacturing and processing units alongside 8.05 million MSMEs in 2022.
02 · Category
Market Size5 stats
01
9.5% CAGR for India’s nutraceuticals market forecast for 2024–2032 per IMARC Group
02
India is the world’s second-largest market for nutraceuticals by value (global rank in the nutraceuticals market outlook) per GlobalData’s market outlook coverage referenced in trade reporting
03
USD 1.6 billion in 2020 is the value of medicinal plant exports from India (exports of medicinal plants, aligned to trade records).
04
9.4% CAGR is the projected growth rate for India’s probiotic market over 2024–2030 (market forecast, probiotics as a major nutraceutical segment).
05
₹61,000 crore is the projected India functional food market size in 2027 (functional foods as a closely related category to nutraceuticals).
Interpretation
Market Size Interpretation
India’s nutraceutical market is set to keep expanding fast with a projected 9.5% CAGR through 2032, and its closely related functional foods segment is forecast to reach ₹61,000 crore by 2027, signaling strong and growing market size momentum.
03 · Category
Industry Trends2 stats
01
Vitamin and mineral supplements accounted for the largest share in India’s dietary supplement sales in 2021 (industry panel share statistic) per Euromonitor research excerpt published by an approved media partner
02
India is among the top global exporters of medicinal plants: exports of medicinal plants from India were valued at USD 1.6 billion in 2020 (ITC/UN Comtrade-aligned reporting cited by TRAFFIC/WWF trade publication)
Interpretation
Industry Trends Interpretation
In the India nutraceutical industry, vitamin and mineral supplements led dietary supplement sales in 2021 with the largest share, while exports of medicinal plants reached $1.6 billion in 2020, underscoring a clear industry trend of strong demand for core micronutrients alongside robust global supply of plant-based ingredients.
More related reading
04 · Category
Cost Analysis9 stats
01
India’s retail sales of packaged foods grew at a double-digit rate in 2023 (context for nutraceutical packaging and distribution), with packaged food sales growth reported at 12% YoY in 2023 by a public industry dataset
02
India’s food inflation averaged about 6% in 2023 (context for nutraceutical ingredient and logistics costs) per RBI’s inflation report data table
03
India’s wholesale price inflation (WPI) for food articles was around 7% in 2022 (cost pressure on ingredients and processing) per RBI WPI series bulletin data
04
Road freight accounts for 60% of India’s inland freight by volume (logistics cost driver) per World Bank/IMF trade facilitation data used in the same logistics cost study
05
India’s labor cost index increased by about 6% in 2022 (manufacturing operating cost context) per Government of India Labour Bureau—Employment and Earnings/Index series
06
India’s manufacturing gross value added (GVA) grew at 7.6% in 2022–23 (operating environment for nutraceutical processors) per MOSPI national accounts press release
07
India’s inland freight is dominated by road transport, with road freight representing 60% of freight volume (logistics constraint affecting nutraceutical ingredient flow).
08
India’s manufacturing sector gross value added (GVA) grew by 7.6% in 2022–23 (macro operating condition for nutraceutical manufacturing).
09
India’s cost of freight and logistics is materially impacted by high fuel price volatility; fuel prices rose in 2023 relative to 2022 (energy cost driver affecting cold-chain and distribution).
Interpretation
Cost Analysis Interpretation
With food inflation averaging around 6% in 2023 and road freight making up 60% of inland freight by volume, nutraceutical costs in India are being pushed from both ingredient pricing and logistics, while labor costs rose about 6% in 2022 and food wholesale inflation was near 7% in 2022, tightening margins for manufacturers even as the operating environment improved with 7.6% manufacturing GVA growth in 2022–23.
05 · Category
User Adoption8 stats
01
In a 2022 consumer survey published in an Indian public health journal, 48% of surveyed Indian adults reported using health supplements to manage energy/health goals (survey-based adoption statistic)
02
A 2021 systematic review on dietary supplement use in India reported pooled prevalence of supplement use around 30% across included studies (meta-analytic adoption statistic)
03
In a 2020 cross-sectional study in an Indian urban population, 63% of participants reported willingness to purchase immunity-related supplements during outbreaks (adoption intent statistic)
04
India’s internet users reached about 750 million in 2023 (digital discovery and e-commerce adoption for supplements), per DataReportal (ITU/World Bank-aligned inputs)
05
The share of consumers in India who are ‘influenced by online reviews’ was 78% in 2023 (marketing and adoption lever for nutraceutical brands) per a public survey dataset
06
India’s e-pharmacy market size in 2023 was around ₹2,500 crore with strong YoY growth (online channel adoption relevant for supplement/adjacent categories) per industry report summary
07
30.4% is the pooled prevalence of dietary supplement use reported across included studies in an India-focused systematic review (meta-analytic estimate).
08
2 in 3 adults (67%) reported using some form of complementary medicine in India in a national survey (health behavior context for nutraceutical adoption).
Interpretation
User Adoption Interpretation
For user adoption, supplement uptake in India is already substantial with around 48% of adults reporting use in 2022 and a pooled prevalence near 30% in 2021, while strong online pull is evident as 78% of consumers are influenced by online reviews and internet scale reached about 750 million users in 2023, making digital channels key to accelerating adoption.
06 · Category
Performance Metrics3 stats
01
₹3,500+ crore is the annual market size for probiotics in India in 2023 (major nutraceutical segment used for gut-health supplementation).
02
₹2,500 crore is the India e-pharmacy market size in 2023 (online channel revenue for medicines that often includes supplement bundles).
03
A 30-day supply chain lead-time reduction was reported after expanding warehouse capacity in Indian consumer health logistics (performance metric tied to distribution speed).
Interpretation
Performance Metrics Interpretation
With India’s probiotics market hitting ₹3,500+ crore in 2023 and the e-pharmacy market reaching ₹2,500 crore the same year, the performance metrics point to rapid growth in gut-health demand and faster digital fulfillment, further reinforced by a reported 30-day supply chain lead-time reduction after warehouse expansion.
report visual · Key figures
India nutraceutical momentum: growth outlook & adoption signals
Forecast growth is supported by rising market demand and broad consumer adoption signals for health supplements and related wellness products.
9.5%
9.5% CAGR for India’s nutraceuticals market forecast for 2024–2032 per IMARC Group
9.4%
9.4% CAGR is the projected growth rate for India’s probiotic market over 2024–2030 (market forecast, probiotics as a maj
48%
In a 2022 consumer survey published in an Indian public health journal, 48% of surveyed Indian adults reported using hea
30%
A 2021 systematic review on dietary supplement use in India reported pooled prevalence of supplement use around 30% acro
78%
The share of consumers in India who are ‘influenced by online reviews’ was 78% in 2023 (marketing and adoption lever for
source-verifiedimarcgroup.com · fortunebusinessinsights.com · ncbi.nlm.nih.gov · wearemarketing.com2024
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Sophie Moreland. (2026, February 13). India Nutraceutical Industry Statistics. Gitnux. https://gitnux.org/india-nutraceutical-industry-statistics
MLA
Sophie Moreland. "India Nutraceutical Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/india-nutraceutical-industry-statistics.
Chicago
Sophie Moreland. 2026. "India Nutraceutical Industry Statistics." Gitnux. https://gitnux.org/india-nutraceutical-industry-statistics.
Sources & references
30 datasets cited across this report · attribution is report-level
+6 additional datasets cited (not shown individually)